A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas

Adult Male Science Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Humans; Male; MicroRNAs; Middle Aged; Neoplasm Invasiveness; Phenotype; Prognosis; Agricultural and Biological Sciences (all); Biochemistry, Genetics and Molecular Biology (all); Medicine (all) 03 medical and health sciences 0302 clinical medicine Biomarkers, Tumor Humans Neoplasm Invasiveness Aged Brain Neoplasms Gene Expression Profiling Q R Glioma Middle Aged Prognosis 3. Good health Gene Expression Regulation, Neoplastic MicroRNAs Phenotype Medicine Female miRNA; glioma; prognosis Research Article
DOI: 10.1371/journal.pone.0108950 Publication Date: 2014-10-03T17:52:15Z
ABSTRACT
Gliomas represent a disparate group of tumours for which there are to date no cure. Thus, is recognized need new diagnostic and therapeutic approaches based on increased understanding their molecular nature. We performed the comparison microRNA (miRNA) profile 8 WHO grade II gliomas 24 higher (2 III 22 glioblastomas) by using Affymetrix GeneChip miRNA Array v. 1.0. A relative quantification method (RT-qPCR) with standard curve was used confirm signature resulted array analysis. The prognostic performances confirmed miRNAs were estimated Tumor Cancer Genome Atlas (TCGA) datasets. identified distinguishing from tumours. RT-qPCR differential expression in two patients' groups 13 out miRNAs. analysis Glioblastoma Multiforme (GBM) Lower Grade Glioma (LGG) datasets TCGA demonstrated association prognosis 6 those Moreover, GBM dataset miR-21 miR-210 predictors worse both univariable multivariable Cox regression analyses (HR 1.19, p = 0.04, HR 1.18, 0.029 respectively). Our results support direct contribution glioma cancerogenesis suggest that may play role aggressive clinical behaviour glioblastomas.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (21)
CITATIONS (51)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....